Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus	Active, not recruiting	Not stated	2026-06-11		NCT02710370

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Harvard University	37
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
National Institutes of Health (NIH)	667
University of Pittsburgh	313

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Magee-Womens Hospital of UPMC	Pittsburgh	United States	7